Biosciences
Ivermectin to reduce malaria transmission- safety and efficacy results from the BOHEMIA cluster randomized trial in Mozambique.Chaccour C, Nicolas P, Martinho S, Mundaca H, Elobolobo E, Ruiz-Castillo P, Houana A, Montaña J, Mbanze J, Casellas A, Macucha A, Mael M, Soares A, Kiuru C, Gutierrez AS, Imputiua S, Constantino L, Vegove V, Cole G, Duthaler U, Ribes M, Mutepa V, Brew J, Munguambe H, Stanulovic S, Xerinda A, Materula F, Gorski N, Wanjiku C, Furnival-Adams J, Túnez L, Sam L, Collins L, Xia K, Hammann F, Rudd M, Rist C, Jones C, Maia M, Candrinho B, Rabinovich NR, Saute F
EClinicalMedicine, (2025). 90:103632
Access to hypertension services and health-seeking experiences in rural Coastal Kenya: A qualitative study.Oyando R, Kagwanja N, Diallo BA, Hassan S, Badjie J, Lucinde R, Mumba N, Kinyanjui SM, Perel P, Etyang A, Barasa E, Nolte E, Tsofa B
PLOS Glob Public Health, (2025). 5:e0004324
Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.Abdel Hamid MM, Abdelraheem MH, Acheampong DO, Adam I, Aide P, Ajibaye O, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amenga-Etego L, Aniebo I, Aninagyei E, Ansah F, Apinjoh TO, Ariani CV, Auburn S, Awandare GA, Balmer A, Bejon P, Boene S, Bwire G, Candrinho B, Chidimatembue A, Chindavongsa K, Comiche K, Conway D, Dara A, Diakite M, Djimde A, Dondorp A, Doumbia S, Drury E, Fanello CA, Ferdig M, Figueroa K, Gamboa D, Golassa L, Gonçalves S, Guindo MDA, Hamaluba M, Hanboonkunupakarn B, Howe K, Hussien M, Imwong M, Ishengoma D, Jeans J, Kabaghe A, Kamuhabwa A, Kindermans JM, Konate DS, Kwiatkowski DP, Lee C, Lee SK, Lee SJ, Ley B, Llanos-Cuentas A, Marfurt J, Matambisso G, Maude RR, Maude RJ, Mayor A, Mayxay M, Maïga-Ascofaré O, McCann RS, Miles A, Miotto O, Mohamed AO, Morang'a CM, Murie K, Ngasala BE, Nguyen TN, Nolasco O, Nosten F, Noviyanti R, O'Connor à Oboh M, Ochola-Oyier LI, Olufunke Falade C, Olukosi A, Olumide A, Olusola FI, Onyamboko MA, Oriero EC, Oyibo WA, Pannebaker D, Pearson RD, Phiri K, van der Pluijm RW, Price RN, Quang HH, Rajkumar Devaraju V, Randrianarivelojosia M, Ranford-Cartwright L, Rayner JC, Rovira-Vallbona E, Rowlands K, Ruano-Rubio V, Sanchez JF, Saúte F, Shettima S, da Silva C, Simpson VJ, Suddaby S, Takken W, Thu AM, Toure M, Unlu E, Valdivia HO, van Vugt M, Waithira N, Wellems T, Wendler J, White N, Wuendrich Ogidan R
Wellcome Open Res, (2025). 10:325
A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): toward a National Surveillance Framework and Data Repository.Wamae K, Magudha J, Asiimwe E, Kimani K, Kandie R, Keitany K, Snow RW, Ochola-Oyier LI
Malar J, (2025). 24:413
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial.Anywaine Z, Serwanga J, Ggayi AM, Abaasa AM, Wright D, Gombe B, Ejou P, Namata T, Kigozi A, Tukamwesiga N, Basajja V, Ankunda V, Mulondo DJ, Nambaziira F, Kakande A, Kakeeto W, Nabaggala P, Jenkin D, Lawrie A, Folegatti P, Tran N, Hansen C, Elliott AM, Hill AVS, Warimwe GM, Kaleebu P
Lancet Infect Dis, (2025). :
Serial cross-sectional school surveys identifies C469Y, P553L, R561H and A675V kelch 13 mutations associated with artemisinin resistance in Western Kenya.Osoti V, Wamae K, Musau MM, Magudha JB, Ndwiga L, Gichuki PM, Okoyo C, Rosebella K, Mahugu S, Aricha S, Kandie R, Keitany K, Kepha S, Mwandawiro C, Bejon P, Snow RW, Ochola-Oyier LI
Sci Rep, (2025). 15:38303
MALDI-TOF MS for malaria vector surveillance: A cost-comparison analysis using a decision-tree approach.Karisa J, Rist C, Tuwei M, Ominde K, Bartilol B, Ondieki Z, Musani H, Wanjiku C, Mwangangi J, Mbogo C, Rono M, Bejon P, Maia M
PLoS One, (2025). 20:e0335764
A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK, Gathuri H, Mwaniki P, Orindi B, Otieno EO, Mwakio S, Mulemi L, Isaaka L, Shangala J, Saisi M, Isinde E, Oginga IN, Wachira AW, Manuthu E, Kariuki H, Asaava P, Nyikuli J, Wekesa C, Otedo A, Bosire H, Okoth SB, Ongalo W, Mukabi DM, Lusamba W, Muthui B, Adembesa I, Mithi C, Sood M, Aliyan NA, Gituma B, Matiko MG, Omondi CA, Ombajo LA, Kirui N, Ochola L, Abdi AI, Kagucia EW, English M, Hamaluba M, Ochola-Oyier I, Kamuya D, Bejon P, Barasa E, Agweyu A, Akech S, Etyang AO
N Engl J Med, (2025). :
Validation of High-throughput Oxford Nanopore Technology for HIV-1 Transmitted/Founder Virus Identification.Byamukama D, Ndekezi C, Omara D, Nakyanzi A, Natwijuka F, Kato F, Mugaba S, Kimuda MP, Kapaata A, Nduati E, Kaleebu P, Balinda SN
Int J Infect Dis, (2025). :108138
Genetic isolation drives divergent insecticide resistance between coastal and western Kenya Anopheles funestus populations.Polo B, Milanoi S, Omoke DN, Odhiambo CA, Nagi SC, Nwezeobi J, Makunin AI, Boddé M, Abong'o B, Midega J, Kamau L, Onguru D, Miles A, Lawniczak M, Ochomo E
Sci Rep, (2025). 15:35920
Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.Ogwang R, Adan M, Bejon P, Kapulu MC
Front Immunol, (2025). 16:1672945
Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants' Full-Length Spikes in a Multiplex Luminex Assay.Waweru G, Nyakundi R, Kutima B, Owuor S, Konyino G, Gitonga J, Lugano D, Maina A, Musyoki J, Ochola L, Omondi M, Kariuki CK, Ogongo P, Mwachari C, Shee F, Agoti C, Sande C, Uyoga S, Kagucia E, Agweyu A, Bejon P, Scott JAG, Warimwe GM, Ochola-Oyier LI, Nyagwange J
Viruses, (2025). 17:
Induction of an early IFN-γ cellular response and high plasma levels of SDF-1α are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patients.Wanjiku P, Orindi B, Kimotho J, Sayed S, Shah R, Saleh M, Mwacharo J, Maronga C, Olouch V, Karanu A, Shah J, Nneka Z, Ochola-Oyier LI, Abdi AI, Dunachie S, Bejon P, Nduati EW, Ndungu FM
PLoS One, (2025). 20:e0316967
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave.Lambisia AW, Katama EN, Moraa E, Mwita JM, Gallagher K, Mutunga M, Nyale E, Omungala J, Mwanga M, Murunga N, Nyiro J, Nyagwange J, Sande C, Bejon P, Githinji G, Dellicour S, Phan MVT, Cotten M, Ochola-Oyier LI, Holmes EC, Agoti CN
BMC Glob Public Health, (2025). 3:80
MALDI-TOF MS for identification of Afro-tropical secondary malaria vectors.Tuwei M, Karisa J, Wanjiku C, Kiuru C, Ondieki Z, Odongo T, Mure F, Otieno B, Meli P, Okoko M, Bartilol B, Gona R, Constantino L, Cole G, Anastácio T, Armazia R, Alves C, Rui P, Ramaita E, Rono M, Candrinho B, Mwangangi J, Mbogo C, Charlwood D, Saute F, Rabinovich R, Chaccour C, Maia MF
Malar J, (2025). 24:284
Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis.Chen I, Miller SL, Msellemu D, Lugenge AG, Swai JK, Achee N, Andrés M, Bibbs CS, Chareonviriyaphap T, Charlwood JD, Devine G, Elman N, Fillinger U, Flores-Mendoza C, Gibson S, Govella N, Gowelo S, Horstmann S, Kawada H, Kline D, Lloyd A, Lobo NF, Maia MF, Mmbando A, Moreno-Gómez M, Morrison AC, Mponzi W, Mwanga EP, Njoroge M, Ogoma SB, Okumu FO, Opiyo M, Oumbouke WA, Paliga J, Pongsiri A, Ponlawat A, Saeaung M, Salazar F, Sangoro O, Stevenson JC, Sukkanon C, Syafruddin D, Tambwe MM, Tangena JA, Vajda EA, Vazquez-Prokopec G, Wagman JM, Yan C, Allen IE, Moore SJ
EBioMedicine, (2025). :105891
Advancing the course of HIV genomics research in Africa.Agamah FE, Arbuthnot P, Tindana P, Munung NS, Kasule M, Ghansah A, Mosepele M, Gaolathe T, Kekitiinwa A, Nduati E, Jumare J, Gómez-Olivé FX, Liebenberg L, Dandara C, Osawe S, Julius R, Muzambi T, Natus T, Omumbo J, Mayne E, Abimiku A, Richardson S, Matshaba M, Skelton M
BMJ Glob Health, (2025). 10:
Making MALDI-TOF MS for entomological parameters accessible: A practical guide for in-house library creation.Karisa J, Tuwei M, Ominde K, Bartilol B, Ondieki Z, Musani H, Rono M, Mbogo C, Bejon P, Mwangangi J, Wanjiku C, Maia M
PLoS One, (2025). 20:e0330605
Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa.Kato F, Kapaata A, Galiwango R, Nakyanzi A, Ndekezi C, Natwijuka F, Omara D, Obuku AE, Foley B, Kaleebu P, Nduati E, Balinda SN
Front Microbiol, (2025). 16:1632581
Rift Valley fever seroprevalence and risk factors among human populations in Uganda's cattle corridor: a cross-sectional study.Anywaine Z, Wright D, Warimwe GM, Kaleebu P, Elliott A, Hansen C
BMJ Public Health, (2025). 3:e002563
